E. Ortega-Brria Et Al. , "Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents," VACCINE , vol.25, no.50, pp.8432-8440, 2007
Ortega-Brria, E. Et Al. 2007. Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents. VACCINE , vol.25, no.50 , 8432-8440.
Ortega-Brria, E., Kanra, G., Leroux, G., Bravo, L., Safary, A., & Lefevre, I., (2007). Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents. VACCINE , vol.25, no.50, 8432-8440.
Ortega-Brria, Eduardo Et Al. "Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents," VACCINE , vol.25, no.50, 8432-8440, 2007
Ortega-Brria, Eduardo Et Al. "Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents." VACCINE , vol.25, no.50, pp.8432-8440, 2007
Ortega-Brria, E. Et Al. (2007) . "Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents." VACCINE , vol.25, no.50, pp.8432-8440.
@article{article, author={Eduardo Ortega-Brria Et Al. }, title={Immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents}, journal={VACCINE}, year=2007, pages={8432-8440} }